Trial Profile
Phase II study of combination therapy with Irinotecan and S-1 in patients with progressive colorectal cancer after FOLFOX regimen
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 May 2017
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 30 Apr 2017 Status changed from active, no longer recruiting to completed.
- 02 Sep 2008 New trial record.